Euphrates Vascular, Inc.

Amendment
CIK: 0001752992·Biotechnology·DELAWARE·Filed: Oct 3, 2023
Total Offering

$9,084,802

Amount Sold

$9,084,802

Investors

33

First Sale

Jul 15, 2020

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
Sean Morris
Related Person
Martin Omid Akhavan
Related Person
Cathy Matthes
Related Person

Company

Euphrates Vascular, Inc.

8460 Watson Road

St. Louis, MO, 63119

518-944-3367

SEC Filing

0001752992-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Euphrates Vascular, Inc. Form D Filing — $9,084,802 | FilingFlow